Society for Clinical Vascular Surgery
February 26, 2007

A parallel group observational study of Supra-Renal Aortic aneurysm Repair (SRAR), Juxtarenal Aneurysm Repair (JRAR) and Infrarenal Aortic Aneurysm Repair (IRAR). Does Single Suprarenal Artery clamping alter technical and clinical outcome in Para-Renal Aortic Repair?

Back to Annual Meeting
Back to Program
Niamh Hynes, MB BCh MCh MD MRCSI, Wael Tawfick, MB BCh BAO MRCSI, Sherif Sultan, MB BCh MCh MD FRCSI DEVS DMD FRCS (Gen-Vasc) EBQS.
Western Vascular Institute, Galway, Ireland.

Objectives: Approximately 60% of IRAs are suitable for endovascular repair. Consequently relative numbers of open para-renal AAAs are mounting. We aim to equate clinical and technical outcome for open JRAR and SRAR with IRAR.
Methods: Of 110 consecutive open AAA repairs from 2002-2005, 64 were IRAR (34 emergent), 46 para-renal AAA of which 16 SRAR (8 emergent), 30 JRAR (8 emergent). All para-renal AAA had left renal vein division. The proximal aortic clamp placed obliquely, preserving blood supply to the highest renal artery, with no perfusion-shunting. Renal arteries were re-implanted in four cases; the IMA in three cases. Peri-operatively we used N-acetylcysteine, intravenous Saline, 20%Mannitol, antibiotics, Heparin, iloprost and cell-saver-auto-transfusion device.
Results: Groups were matched for age (p=0.766, mean+/-SD: IRAR=73+/-7years, JRAR=73.7+/-8years, SRAR=72.1+/-6years), sex (80%male) and mean aneurysm size (p=0.134, IRAR=6.5 +/-1.6cm, JRAR=7.1 +/-1.6cm, SRAR=7+/-1.9cm). Using multivariate analysis, only Diabetes was associated with adverse outcome (p=0.02, RR=0.35 (95%CI: 0.14-0.84)). Post-operative renal-impairment rates did not vary significantly (IRAR 25%, JRAR=20% SRAR 25%, p=0.863).
Mean hospital stay was similar between groups. (p=0.166, IRAR=20.6+/-20.9 days, JRAR=15.2+/-9.8days, SRAR=26.4+/-25.5days), as was ICU/HDU stay (p=0.373, IRAR=8.3+/-17.5days, JRAR= 5.1+/-5.4days, SRAR=11.1+/-9days)

3-year elective-survival-rate for SRAR was 100%. 3-year-rates for IRAR and JRAR were similar (82.1% v 81.7%, p=0.852, RR=0.87 [95%CI=0.20-3.74]). 3-year emergency-survival-rate for IRAR (52.9%) were similar to JRAR (53.4%, p=0.973, RR=0.98 [95%CI=0.38-2.51]) and SRAR (62.5%, p=0.701, RR=1.27 [95%CI=0.41-3.97])
Conclusions: Outcomes analogous to IRAR are realistic for JRAR and SRAR with single-renal clamping, left renal vein transfixion, minimal visceral-ischaemia time and peri-operative pharmacological manipulation.


Back to Annual Meeting
Back to Program